Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes.

Toxins
Vineet I PatelJordan P Metcalf

Abstract

Bacillus anthracis, the causative agent of inhalation anthrax, is a serious concern as a bioterrorism weapon. The vegetative form produces two exotoxins: Lethal toxin (LT) and edema toxin (ET). We recently characterized and compared six human airway and alveolar-resident phagocyte (AARP) subsets at the transcriptional and functional levels. In this study, we examined the effects of LT and ET on these subsets and human leukocytes. AARPs and leukocytes do not express high levels of the toxin receptors, tumor endothelium marker-8 (TEM8) and capillary morphogenesis protein-2 (CMG2). Less than 20% expressed surface TEM8, while less than 15% expressed CMG2. All cell types bound or internalized protective antigen, the common component of the two toxins, in a dose-dependent manner. Most protective antigen was likely internalized via macropinocytosis. Cells were not sensitive to LT-induced apoptosis or necrosis at concentrations up to 1000 ng/mL. However, toxin exposure inhibited B. anthracis spore internalization. This inhibition was driven primarily by ET in AARPs and LT in leukocytes. These results support a model of inhalation anthrax in which spores germinate and produce toxins. ET inhibits pathogen phagocytosis by AARPs, allowing ...Continue Reading

References

Jan 1, 1977·Scandinavian Journal of Immunology·G Kaplan
Mar 1, 1976·The Journal of Cell Biology·R M SteinmanZ A Cohn
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K R KlimpelS H Leppla
Jan 1, 1985·Infection and Immunity·J O'BrienS Leppla
Dec 1, 1965·The Journal of Infectious Diseases·R E LincolnJ S Walker
Mar 1, 1968·Journal of Bacteriology·D C FishR E Lincoln
Jul 16, 1984·European Journal of Biochemistry·M Birmelin, K Decker
Oct 15, 1984·Mechanisms of Ageing and Development·T FülöpA Leövey
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H Leppla
Nov 18, 1994·Science·M MeselsonO Yampolskaya
Sep 1, 1994·American Journal of Respiratory Cell and Molecular Biology·J M van HaarstH A Drexhage
Jun 1, 1993·The Journal of Cell Biology·E L Racoosin, J A Swanson
May 23, 1998·Science·N S DuesberyG F Vande Woude
Feb 13, 1999·Molecular Microbiology·C Guidi-RontaniM Mock
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Apr 27, 2000·Nature Cell Biology·R C MayL M Machesky
Nov 9, 2001·Nature·K A BradleyJ A Young
Jun 11, 2002·Biochemical and Biophysical Research Communications·Serguei G PopovKen Alibek
Sep 10, 2002·Trends in Microbiology·Chantal Guidi-Rontani
Oct 25, 2002·Emerging Infectious Diseases·Daniel B JerniganUNKNOWN National Anthrax Epidemiologic Investigation Team
Jan 29, 2003·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Apr 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Heather M ScobieJohn A T Young
Jan 1, 1965·Journal of Bacteriology·B W HAINESR E LINCOLN
Sep 27, 2003·American Journal of Respiratory and Critical Care Medicine·Matthias OchsHans Jørgen G Gundersen
Dec 23, 2003·Infection and Immunity·James E Kirby
Feb 12, 2004·Cancer Research·Akash NandaBrad St Croix
Jan 7, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·David M AronoffMarc Peters-Golden
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katherine C BrittinghamSina Bavari
Aug 10, 2005·The Journal of Infectious Diseases·Russell L DuringFrederick S Southwick
Mar 7, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia JakubzickGwendalyn J Randolph
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hui FangDavid M Frucht
Jun 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew A CrawfordGary M Bokoch

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
Bronchoalveolar
lavage
X-ray
bronchoalveolar collections

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved